Foresite Capital Management IV, LLC / CYTK
Foresite Capital Management IV, LLC’s Cytokinetics Inc Position
Does Foresite Capital Management IV, LLC own Cytokinetics Inc (CYTK)? Yes — 503.3K shares worth $33M (+13.99% of its 13F portfolio) as of Q1 2026, up from 458.3K shares the prior filed quarter.
Position Value
$33M
Q1 2026
Shares
503.3K
% of Portfolio
+13.99%
Quarters Held
13
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 503.3K | $33M | +13.99% |
| Q4 2025 | 458.3K | $29M | +12.68% |
| Q3 2025 | 458.3K | $25M | +13.79% |
| Q2 2021 | 545.1K | $11M | +1.46% |
| Q1 2021 | 881.9K | $21M | +2.46% |
| Q4 2020 | 1.44M | $30M | +3.24% |
| Q3 2020 | 1.67M | $36M | +8.16% |
| Q2 2020 | 1.61M | $38M | +18.45% |
| Q1 2020 | 2.18M | $26M | +31.64% |
| Q4 2019 | 2.40M | $25M | +10.98% |
| Q3 2019 | 1.90M | $22M | +6.98% |
| Q2 2019 | 1.90M | $21M | +6.04% |
| Q1 2019 | 1.72M | $14M | +5.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of CYTK.